Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jefim Brodkin"'
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22af66185e03584106c6c5f68525d24b
https://doi.org/10.1158/0008-5472.22426408.v1
https://doi.org/10.1158/0008-5472.22426408.v1
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aa0b8504d5f3cc210c4d0c5e366bb13
https://doi.org/10.1158/0008-5472.22426411.v1
https://doi.org/10.1158/0008-5472.22426411.v1
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Abnormal vasculature in tumors leads to poor tissue perfusion and cytostatic drug delivery. Although drugs inducing vascular normalization, for example, angiopoietin-2 (Ang2)-blocking antibodies, have shown promising results in preclinical tumor mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81085bb06873c195d8de4fe9f11b70c1
https://doi.org/10.1158/0008-5472.c.6512332
https://doi.org/10.1158/0008-5472.c.6512332
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d1ec2d2031353982c4a6e8f83179d3
https://doi.org/10.1158/0008-5472.22426396
https://doi.org/10.1158/0008-5472.22426396
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39933ef62fae6f760e96bd2a770daeaa
https://doi.org/10.1158/0008-5472.22426417.v1
https://doi.org/10.1158/0008-5472.22426417.v1
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4545f0c0a43b6041800cd0d7429c2e4d
https://doi.org/10.1158/0008-5472.22426405
https://doi.org/10.1158/0008-5472.22426405
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f3bf835572c68ae15076b82d8bdca0
https://doi.org/10.1158/0008-5472.22426402.v1
https://doi.org/10.1158/0008-5472.22426402.v1
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449385c48eacdff4c256cdf523d7451a
https://doi.org/10.1158/0008-5472.22426399
https://doi.org/10.1158/0008-5472.22426399
Autor:
Kari Alitalo, Emilia A. Korhonen, Jefim Brodkin, Marianne Lähde, Sarika Heino, Suvendu Das, Jenny Högström, Elina Jokinen, Pauliina Kallio
Supplementary Figure S2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633e514578c7921bcff25a54c012639c
https://doi.org/10.1158/0008-5472.22426414.v1
https://doi.org/10.1158/0008-5472.22426414.v1
Autor:
Jenny Högström, Emilia A. Korhonen, Elina Jokinen, Suvendu Das, Marianne Lähde, Jefim Brodkin, Kari Alitalo, Sarika Heino, Pauliina Kallio
Publikováno v:
Cancer Research. 80:2639-2650
Abnormal vasculature in tumors leads to poor tissue perfusion and cytostatic drug delivery. Although drugs inducing vascular normalization, for example, angiopoietin-2 (Ang2)-blocking antibodies, have shown promising results in preclinical tumor mode